A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status
Background: Comorbidity and socioeconomic status (SES) may be related among cancer patients. Method: Population-based cancer registry study among 72 153 patients diagnosed during 1997–2006. Results: Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was...
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 2010-11, Vol.103 (11), p.1742-1748 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1748 |
|---|---|
| container_issue | 11 |
| container_start_page | 1742 |
| container_title | British journal of cancer |
| container_volume | 103 |
| creator | Louwman, W J Aarts, M J Houterman, S van Lenthe, F J Coebergh, J W W Janssen-Heijnen, M L G |
| description | Background:
Comorbidity and socioeconomic status (SES) may be related among cancer patients.
Method:
Population-based cancer registry study among 72 153 patients diagnosed during 1997–2006.
Results:
Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest
vs
highest SES, partly explained by comorbidity.
Conclusion:
This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions. |
| doi_str_mv | 10.1038/sj.bjc.6605949 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2994221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904466336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-87001ab5d1dca1f1d615b2779f5dd11f9965e6a26db66e574765701f9c8699063</originalsourceid><addsrcrecordid>eNqFkc1rFDEYxoModq1ePUoQiqfZJpnJ10UoxS8oeNFzyGQyOxlmkm3emRb_e7Ps2qognkLy_J73Iw9CrynZUlKrSxi37ei2QhCuG_0EbSivWUUVk0_RhhAiK6IZOUMvAMZy1UTJ5-iMES0VJ2qDbq8wJxd4CLvBZ7zP_s5OPjqPU4-n0PsKhpQXH0PcYTfkFIPDLsUuLCFFwHZOB8EWR3HbJfi4AL4Py4CndI8huZB84dNcfLDYZYWX6FlvJ_CvTuc5-v7xw7frz9XN109frq9uKsepWiolCaG25R3tnKU97QTlLZNS97zrKO21FtwLy0TXCuG5bKTgkpR3p4TWRNTn6P2x7n5tZ9-5Mlm2k9nnMNv8wyQbzJ9KDIPZpTvDtG4Yo6XAu1OBnG5XD4uZAzg_TTb6tILRpGmEqGvxX1JRRpmQShfy7V_kmNYcyz8UiNOaK80LtD1CLieA7PuHoSkxh9QNjKakbk6pF8Ob31d9wH_FXICLE2DB2anPJbAAj1zZgRJ1WOTyyEGR4s7nx_H-0fonYFLG4w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815135895</pqid></control><display><type>article</type><title>A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Louwman, W J ; Aarts, M J ; Houterman, S ; van Lenthe, F J ; Coebergh, J W W ; Janssen-Heijnen, M L G</creator><creatorcontrib>Louwman, W J ; Aarts, M J ; Houterman, S ; van Lenthe, F J ; Coebergh, J W W ; Janssen-Heijnen, M L G</creatorcontrib><description>Background:
Comorbidity and socioeconomic status (SES) may be related among cancer patients.
Method:
Population-based cancer registry study among 72 153 patients diagnosed during 1997–2006.
Results:
Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest
vs
highest SES, partly explained by comorbidity.
Conclusion:
This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6605949</identifier><identifier>PMID: 20978508</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699 ; 692/699/67 ; 692/699/67/2324 ; 706/689/523 ; Adult ; Aged ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Bladder ; Cancer Research ; Cardiovascular disease ; Cardiovascular Diseases - etiology ; Cerebrovascular disease ; Cervix ; Chronic Disease ; Chronic illnesses ; Comorbidity ; Dementia ; Diabetes ; Diabetes Mellitus - etiology ; Drug Resistance ; Epidemiology ; Female ; Gastrointestinal diseases ; Humans ; Lymphoma ; Male ; Medical research ; Medical sciences ; Melanoma ; Middle Aged ; Molecular Medicine ; Mycobacterium ; Neoplasms - complications ; Neoplasms - mortality ; Oncology ; Ovaries ; Prevalence ; Prostate ; Social Class ; Socioeconomic factors ; Tuberculosis ; Tumors</subject><ispartof>British journal of cancer, 2010-11, Vol.103 (11), p.1742-1748</ispartof><rights>The Author(s) 2010</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Nov 23, 2010</rights><rights>Copyright © 2010 Cancer Research UK 2010 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-87001ab5d1dca1f1d615b2779f5dd11f9965e6a26db66e574765701f9c8699063</citedby><cites>FETCH-LOGICAL-c518t-87001ab5d1dca1f1d615b2779f5dd11f9965e6a26db66e574765701f9c8699063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994221/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994221/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23631086$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20978508$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Louwman, W J</creatorcontrib><creatorcontrib>Aarts, M J</creatorcontrib><creatorcontrib>Houterman, S</creatorcontrib><creatorcontrib>van Lenthe, F J</creatorcontrib><creatorcontrib>Coebergh, J W W</creatorcontrib><creatorcontrib>Janssen-Heijnen, M L G</creatorcontrib><title>A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Background:
Comorbidity and socioeconomic status (SES) may be related among cancer patients.
Method:
Population-based cancer registry study among 72 153 patients diagnosed during 1997–2006.
Results:
Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest
vs
highest SES, partly explained by comorbidity.
Conclusion:
This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions.</description><subject>692/699</subject><subject>692/699/67</subject><subject>692/699/67/2324</subject><subject>706/689/523</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bladder</subject><subject>Cancer Research</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cerebrovascular disease</subject><subject>Cervix</subject><subject>Chronic Disease</subject><subject>Chronic illnesses</subject><subject>Comorbidity</subject><subject>Dementia</subject><subject>Diabetes</subject><subject>Diabetes Mellitus - etiology</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Gastrointestinal diseases</subject><subject>Humans</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Melanoma</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Mycobacterium</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - mortality</subject><subject>Oncology</subject><subject>Ovaries</subject><subject>Prevalence</subject><subject>Prostate</subject><subject>Social Class</subject><subject>Socioeconomic factors</subject><subject>Tuberculosis</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc1rFDEYxoModq1ePUoQiqfZJpnJ10UoxS8oeNFzyGQyOxlmkm3emRb_e7Ps2qognkLy_J73Iw9CrynZUlKrSxi37ei2QhCuG_0EbSivWUUVk0_RhhAiK6IZOUMvAMZy1UTJ5-iMES0VJ2qDbq8wJxd4CLvBZ7zP_s5OPjqPU4-n0PsKhpQXH0PcYTfkFIPDLsUuLCFFwHZOB8EWR3HbJfi4AL4Py4CndI8huZB84dNcfLDYZYWX6FlvJ_CvTuc5-v7xw7frz9XN109frq9uKsepWiolCaG25R3tnKU97QTlLZNS97zrKO21FtwLy0TXCuG5bKTgkpR3p4TWRNTn6P2x7n5tZ9-5Mlm2k9nnMNv8wyQbzJ9KDIPZpTvDtG4Yo6XAu1OBnG5XD4uZAzg_TTb6tILRpGmEqGvxX1JRRpmQShfy7V_kmNYcyz8UiNOaK80LtD1CLieA7PuHoSkxh9QNjKakbk6pF8Ob31d9wH_FXICLE2DB2anPJbAAj1zZgRJ1WOTyyEGR4s7nx_H-0fonYFLG4w</recordid><startdate>20101123</startdate><enddate>20101123</enddate><creator>Louwman, W J</creator><creator>Aarts, M J</creator><creator>Houterman, S</creator><creator>van Lenthe, F J</creator><creator>Coebergh, J W W</creator><creator>Janssen-Heijnen, M L G</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7U1</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20101123</creationdate><title>A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status</title><author>Louwman, W J ; Aarts, M J ; Houterman, S ; van Lenthe, F J ; Coebergh, J W W ; Janssen-Heijnen, M L G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-87001ab5d1dca1f1d615b2779f5dd11f9965e6a26db66e574765701f9c8699063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>692/699</topic><topic>692/699/67</topic><topic>692/699/67/2324</topic><topic>706/689/523</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bladder</topic><topic>Cancer Research</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cerebrovascular disease</topic><topic>Cervix</topic><topic>Chronic Disease</topic><topic>Chronic illnesses</topic><topic>Comorbidity</topic><topic>Dementia</topic><topic>Diabetes</topic><topic>Diabetes Mellitus - etiology</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Gastrointestinal diseases</topic><topic>Humans</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Melanoma</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Mycobacterium</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - mortality</topic><topic>Oncology</topic><topic>Ovaries</topic><topic>Prevalence</topic><topic>Prostate</topic><topic>Social Class</topic><topic>Socioeconomic factors</topic><topic>Tuberculosis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louwman, W J</creatorcontrib><creatorcontrib>Aarts, M J</creatorcontrib><creatorcontrib>Houterman, S</creatorcontrib><creatorcontrib>van Lenthe, F J</creatorcontrib><creatorcontrib>Coebergh, J W W</creatorcontrib><creatorcontrib>Janssen-Heijnen, M L G</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louwman, W J</au><au>Aarts, M J</au><au>Houterman, S</au><au>van Lenthe, F J</au><au>Coebergh, J W W</au><au>Janssen-Heijnen, M L G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2010-11-23</date><risdate>2010</risdate><volume>103</volume><issue>11</issue><spage>1742</spage><epage>1748</epage><pages>1742-1748</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Background:
Comorbidity and socioeconomic status (SES) may be related among cancer patients.
Method:
Population-based cancer registry study among 72 153 patients diagnosed during 1997–2006.
Results:
Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest
vs
highest SES, partly explained by comorbidity.
Conclusion:
This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20978508</pmid><doi>10.1038/sj.bjc.6605949</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 2010-11, Vol.103 (11), p.1742-1748 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2994221 |
| source | MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | 692/699 692/699/67 692/699/67/2324 706/689/523 Adult Aged Biological and medical sciences Biomedical and Life Sciences Biomedicine Bladder Cancer Research Cardiovascular disease Cardiovascular Diseases - etiology Cerebrovascular disease Cervix Chronic Disease Chronic illnesses Comorbidity Dementia Diabetes Diabetes Mellitus - etiology Drug Resistance Epidemiology Female Gastrointestinal diseases Humans Lymphoma Male Medical research Medical sciences Melanoma Middle Aged Molecular Medicine Mycobacterium Neoplasms - complications Neoplasms - mortality Oncology Ovaries Prevalence Prostate Social Class Socioeconomic factors Tuberculosis Tumors |
| title | A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T14%3A08%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%2050%25%20higher%20prevalence%20of%20life-shortening%20chronic%20conditions%20among%20cancer%20patients%20with%20low%20socioeconomic%20status&rft.jtitle=British%20journal%20of%20cancer&rft.au=Louwman,%20W%20J&rft.date=2010-11-23&rft.volume=103&rft.issue=11&rft.spage=1742&rft.epage=1748&rft.pages=1742-1748&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6605949&rft_dat=%3Cproquest_pubme%3E904466336%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815135895&rft_id=info:pmid/20978508&rfr_iscdi=true |